Jumping translocations are common in solid tumor cell lines and result in recurrent fusions of whole chromosome arms
- PMID: 11241788
- DOI: 10.1002/gcc.1101
Jumping translocations are common in solid tumor cell lines and result in recurrent fusions of whole chromosome arms
Abstract
Jumping translocations (JTs) and segmental jumping translocations (SJTs) are unbalanced translocations involving a donor chromosome arm or chromosome segment that has fused to multiple recipient chromosomes. In leukemia, where JTs have been predominantly observed, the donor segment (usually 1q) preferentially fuses to the telomere regions of recipient chromosomes. In this study, spectral karyotyping (SKY) and FISH analysis revealed 188 JTs and SJTs in 10 cell lines derived from carcinomas of the bladder, prostate, breast, cervix, and pancreas. Multiple JTs and SJTs were detected in each cell line and contributed to recurrent unbalanced whole-arm translocations involving chromosome arms 5p, 14q, 15q, 20q, and 21q. Sixty percent (113/188) of JT breakpoints occurred within centromere or pericentromeric regions of the recipient chromosomes, whereas only 12% of the breakpoints were located in the telomere regions. JT breakpoints of both donor and recipient chromosomes coincided with numerous fragile sites as well as viral integration sites for human DNA viruses. The JTs within each tumor cell line promoted clonal progression, leading to the acquisition of extra copies of the donated chromosome segments that often contained oncogenes (MYC, ABL, HER2/NEU, etc.), consequently resulting in tumor-specific genomic imbalances. Published 2001 Wiley-Liss, Inc.
Similar articles
-
Jumping translocations in spontaneous abortions.Cytogenet Cell Genet. 2000;88(1-2):25-9. doi: 10.1159/000015478. Cytogenet Cell Genet. 2000. PMID: 10773659
-
Jumping translocations.Genes Chromosomes Cancer. 2007 Aug;46(8):717-23. doi: 10.1002/gcc.20456. Genes Chromosomes Cancer. 2007. PMID: 17444494 Review.
-
Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma.Genes Chromosomes Cancer. 2001 Mar;30(3):292-8. doi: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1095>3.0.co;2-f. Genes Chromosomes Cancer. 2001. PMID: 11170287
-
Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin.Blood. 1998 Mar 1;91(5):1732-41. Blood. 1998. PMID: 9473240
-
Genetic alterations in cancer as a result of breakage at fragile sites.Cancer Lett. 2003 Mar 20;192(1):1-17. doi: 10.1016/s0304-3835(02)00596-7. Cancer Lett. 2003. PMID: 12637148 Review.
Cited by
-
Spectral karyotyping to study chromosome abnormalities in humans and mice with polycystic kidney disease.J Vis Exp. 2012 Feb 3;(60):3887. doi: 10.3791/3887. J Vis Exp. 2012. PMID: 22330078 Free PMC article.
-
Cycles of chromosome instability are associated with a fragile site and are increased by defects in DNA replication and checkpoint controls in yeast.Genes Dev. 2006 Jan 15;20(2):159-73. doi: 10.1101/gad.1392506. Epub 2005 Dec 29. Genes Dev. 2006. PMID: 16384935 Free PMC article.
-
Molecular Complexes at Euchromatin, Heterochromatin and Centromeric Chromatin.Int J Mol Sci. 2021 Jun 28;22(13):6922. doi: 10.3390/ijms22136922. Int J Mol Sci. 2021. PMID: 34203193 Free PMC article. Review.
-
Using biomarkers of aging to identify modifiable mechanisms underlying age-related risk for cancer.WMJ. 2009 Aug;108(5):280-1. WMJ. 2009. PMID: 19743770 Free PMC article. No abstract available.
-
Development of safer gene delivery systems to minimize the risk of insertional mutagenesis-related malignancies: a critical issue for the field of gene therapy.ISRN Oncol. 2012;2012:616310. doi: 10.5402/2012/616310. Epub 2012 Nov 22. ISRN Oncol. 2012. PMID: 23209944 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous